Omar Ishrak's, Medtronic's CEO, compensation increased 79.8 percent this year, according to StarTribune. The company's fiscal year ended April 30.
Here are five notes:
1. Mr. Ishrak's compensation at the end of the fiscal year totaled $40.5 million, according to a proxy.
2. Around $25.5 million of that was a tax gross-up payment coming out of the Medtronic-Covidien merger.
3. Mr. Ishrak earned $15 million this year before the tax gross-up, compared to $8.3 million he earned last year.
4. His annual incentive bonus was $5.6 million, up from $4.7 million last year.
5. The value of Mr. Ishrak's restricted stock that vested increased from $2.1 million to $7.8 million.